Weekly Enforcement Report: Lab Owners Charged in 2 Fraud Schemes
The owners face fraud charges in two different schemes, one involving urine drug testing and one involving COVID-19 testing.
The owners face fraud charges in two different schemes, one involving urine drug testing and one involving COVID-19 testing.
Recent OIG report says Medicare could have saved up to $215.8 million on at-risk payments for G0483 definitive drug tests.
Recently announced enforcement actions saw three big settlements, with two of those coming from medical centers.
Though labs were again absent from recent key enforcement actions, sentences were handed down in other healthcare-related cases.
Though last week’s cases didn’t involve labs or lab testing, most were FCA-related issues including inflated claims.